A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
Clinical trial NCT06535412 · RECRUITING
Trial details
- NCT number
- NCT06535412
- Sponsor
- ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2028-12-17
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.